Is Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX) Proving The Doubters Wrong?
Biocryst Pharmaceuticals Inc. (BCRX) concluded trading on 01/04/24 at a closing price of $6.46, with 3.96 million shares of worth about $25.57 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -7.18% during that period and on Thursday the price saw a gain of […]
Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX) Stock In Prove Me State
The Vanguard Group, Inc. has recently announced that it has increased stake in Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX) by 2.08%. After grabbing 14.9 million shares, the institutional investor is now in possession of 0.3 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 7.28% having worth around $87.61 million. […]
These Numbers Could Change Investor Views For Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX)
The Vanguard Group, Inc. recently announced the acquisition of new stake in Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX). The institutional investor has increased its shareholding in the Healthcare company by 2.08% to 14.9 million shares with purchase of 0.3 million shares. This fresh investment now brings its stake to 7.28% valued currently at $87.61 million. In addition, […]
Reassessing The Changing Outlook For Biocryst Pharmaceuticals Inc. (BCRX)
The Vanguard Group, Inc. recently announced the acquisition of new stake in Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX). The institutional investor has increased its shareholding in the Healthcare company by 2.08% to 14.9 million shares with purchase of 0.3 million shares. This fresh investment now brings its stake to 7.86% valued currently at $81.8 million. In addition, […]
Is Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX) Proving The Doubters Wrong?
The Vanguard Group, Inc. has recently announced that it has increased stake in Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX) by 2.08%. After grabbing 14.9 million shares, the institutional investor is now in possession of 0.3 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 7.86% having worth around $81.8 million. […]
Biocryst Pharmaceuticals Inc. (NASDAQ: BCRX): Analyst View Points To Future Growth
The Vanguard Group, Inc. has recently announced that it has increased stake in Biocryst Pharmaceuticals Inc. (NASDAQ:BCRX) by 1.55%. After grabbing 14.6 million shares, the institutional investor is now in possession of 0.22 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 7.70% having worth around $103.35 million. […]
